Concepedia
Statistics
Publications
12
Citations
1.4K
H-Index
Active since
1997
Affiliations
University of Messina(Current)
Karolinska Institutet
Uppsala University Hospital
University of Padua
Karolinska University Hospital
M.G. Scordo is an author at University of Messina specializing in pharmacokinetics, pharmacology, and pharmacogenetics.
Publications per year
1997–2016
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance
M.G. Scordo · Clinical Pharmacology & Therapeutics · 2002 · 344 citations
Medicine, Pharmacokinetics, Pharmacology +17
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population
M.G. Scordo · Pharmacological Research · 2004 · 227 citations
Life Sciences, Biology, Genetics +11
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics
Edoardo Spina, Angela Avenoso, G. Facciolá et al. · Psychopharmacology · 2000 · 178 citations
Pharmacy, Pharmacotherapy, Psychiatry +16
Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.
Norio Yasui‐Furukori, Mats Hidestrand, Edoardo Spina et al. · PubMed · 2001 · 154 citations
A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy
Anna‐Karin Hamberg, M-L Dahl, Martina Barban et al. · Clinical Pharmacology & Therapeutics · 2007 · 142 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
1–5 of 12